id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2001-P-0193-0003,FDA,FDA-2001-P-0193,FDA,Notice,N-Notice,2002-10-21T04:00:00Z,2002,10,,,2008-04-25T02:27:23Z,,0,0,09000064804e2aef
FDA-2001-P-0193-0004,FDA,FDA-2001-P-0193,"FDA/CDER to Mallinckrodt, Inc.",Other,LET-Letter,2002-10-21T04:00:00Z,2002,10,,,2008-04-25T02:27:24Z,,0,0,09000064804e2af1
FDA-2001-P-0193-0002,FDA,FDA-2001-P-0193,FDA/CDER to Mallinckrodt,Other,LET-Letter,2002-01-23T05:00:00Z,2002,1,,,2008-04-25T02:27:23Z,,0,0,09000064804e2aec
FDA-2001-P-0193-0001,FDA,FDA-2001-P-0193,"FDA/DDM to Mallinckrodt, Inc.",Other,ACK-Acknowledgement Letter,2001-05-30T04:00:00Z,2001,5,,,2008-04-25T02:27:23Z,,0,0,09000064804e2a9e